StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.36−0.01 (-0.73%)

Close on Nov 19, 2026Market cap $86.67MP/E –Yield –

TuHURA Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

TuHURA Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$29.69M. For fiscal 2025 it was -$27.63M. The highest annual figure on record is -$228.69K in fiscal 2011.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.63M–
FY2023Jun 30, 2023-$11.87M–
FY2022Jun 30, 2022-$20.39M–
FY2021Jun 30, 2021-$18.86M–
FY2020Jun 30, 2020-$7.93M–
FY2019Jun 30, 2019-$6.33M–
FY2018Jun 30, 2018-$9.85M–
FY2017Jun 30, 2017-$8.02M–
FY2016Jun 30, 2016-$5.15M–
FY2013Dec 31, 2013-$5.52M–
FY2012Dec 31, 2012-$578.04K–
FY2011Dec 31, 2011-$228.69K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$8.63M–
Q1 FY2026CQ1 2026Mar 31, 2026-$4.41M–
Q4 FY2025CQ4 2025Dec 31, 2025-$5.56M–
Q3 FY2025CQ3 2025Sep 30, 2025-$11.09M–
Q2 FY2025CQ2 2025Jun 30, 2025-$6.25M–
Q1 FY2025CQ1 2025Mar 31, 2025-$4.74M–
Q4 FY2023CQ2 2023Jun 30, 2023-$1.51M–
Q3 FY2023CQ1 2023Mar 31, 2023-$1.83M–
Q2 FY2023CQ4 2022Dec 31, 2022-$2.16M–
Q1 FY2023CQ3 2022Sep 30, 2022-$6.37M–
Q4 FY2022CQ2 2022Jun 30, 2022-$4.99M–
Q3 FY2022CQ1 2022Mar 31, 2022-$5.22M–
Q2 FY2022CQ4 2021Dec 31, 2021-$5.10M–
Q1 FY2022CQ3 2021Sep 30, 2021-$5.07M–
Q4 FY2021CQ2 2021Jun 30, 2021-$4.69M–
Q3 FY2021CQ1 2021Mar 31, 2021-$4.63M–
Q2 FY2021CQ4 2020Dec 31, 2020-$5.43M–
Q1 FY2021CQ3 2020Sep 30, 2020-$4.11M–
Q4 FY2020CQ2 2020Jun 30, 2020-$2.58M–
Q3 FY2020CQ1 2020Mar 31, 2020-$1.37M–
Q2 FY2020CQ4 2019Dec 31, 2019-$1.71M–
Q1 FY2020CQ3 2019Sep 30, 2019-$2.27M–
Q4 FY2019CQ2 2019Jun 30, 2019-$1.81M–
Q3 FY2019CQ1 2019Mar 31, 2019-$1.46M–
Q2 FY2019CQ4 2018Dec 31, 2018-$964.95K–
Q1 FY2019CQ3 2018Sep 30, 2018-$2.08M–
Q4 FY2018CQ2 2018Jun 30, 2018-$2.53M–
Q3 FY2018CQ1 2018Mar 31, 2018-$2.81M–
Q2 FY2018CQ4 2017Dec 31, 2017-$2.13M–
Q1 FY2018CQ3 2017Sep 30, 2017-$2.37M–
Q4 FY2017CQ2 2017Jun 30, 2017-$3.45M–
Q3 FY2017CQ1 2017Mar 31, 2017-$1.51M–
Q2 FY2017CQ4 2016Dec 31, 2016-$1.45M–
Q1 FY2017CQ3 2016Sep 30, 2016-$1.61M–
Q4 FY2016CQ2 2016Jun 30, 2016-$1.55M–
Q3 FY2016CQ1 2016Mar 31, 2016-$956.92K–
Q2 FY2016CQ4 2015Dec 31, 2015-$1.23M–
Q1 FY2016CQ3 2015Sep 30, 2015-$1.40M–
Q4 FY2013CQ4 2013Dec 31, 2013-$1.03M–
Q3 FY2013CQ3 2013Sep 30, 2013-$1.11M–

More TuHURA Biosciences figures

See a number that looks wrong?